bring together both experienced neurologists in the field of CVD and PET as well as biomathematicians and physicists with expertise in the fields of physi ological modeling.
THE PATHOPHYSIOLOGICAL PROBLEMS
In the acute stage of ischemic stroke, the mea surement of local hemodynamics and energy metab olism offer an insight into the interrelationships of perfusion and neuronal function. For example, the simultaneous measurement of local cerebral blood flow and oxygen consumption permits the delinea tion of tissue ischemia and its distinction from ei ther simple oligemia or reperfusion (Wise et aI., 1983a; Lenzi et aI., 1982; Powers et aI., 1985 Powers et aI., , 1986 Hakim et aI., 1987; Baron et aI., 1981a,b; Baron, 1985; Ackerman et aI., 1985) . In addition, the tran sition from ischemia to actual infarction has been documented by these techniques (Wise et aI., 1983a) although in some instances severe ischemia vanished without morphological damage (Baron et aI., 1987; Powers et aI., 1986 ) and final tissue out come (namely necrosis or integrity) has been asso ciated with initial quantitative values for cerebral blood flow (CBF) and cerebral metabolic rate of O2 (CMR02) (Baron et aI., 1981b (Baron et aI., , 1987 Powers et aI., 1986; Hakim et aI., 1987) . In all of these studies, the quantitative imaging of the oxygen extraction frac tion (OEF, sometimes referred to as OER in the literature) has been shown to be of invaluable help in the assessment of the pattern of CBF-CMR02 coupling. Ideally, glucose utilisation should be mea sured simultaneously with CMR02 in order to pro vide an accurate assessment of local energy metab olism because glucose utilisation and oxygen use may become uncoupled in acute stroke and this un coupling may go in two opposite directions, either aerobic glycolysis where CMR g lc is better preserved than CMR02, or use of other substrates for oxidiza tion than glucose (Wise et aI., 1983b; Baron et aI., 1984; Hakim et aI., 1987) . In addition, mitochon drial uncoupling between oxygen use and ATP pro duction may also occur in acute experimental isch emia (see Siejso, 1978) . The assessment of anaero bic glycolysis by the combined measurement of CMR g lc and CMR02 is also desirable in acute isch emic stroke because severe lactic acidosis is one of the possible mechanisms leading to neuronal death.
Within hours or days after stroke onset, tissue ischemia is followed by reperfusion, which sets in either abruptly or more slowly (Baron et aI., 1981b; Hakim et aI., 1987; Lenzi et aI., 1982; Ackerman et aI., 1981) . Postischemic reactive hyperemia (also called absolute luxury perfusion) is seen as an in creased CBF and a low OER and occurs in necrotic areas as well as in surrounding viable tissue; its importance in aggravating tissue necrosis or en hancing recovery is probably marginal, but it has been shown to enhance vasogenic cerebral edema, presumably through increased protein leakage through a damaged blood-brain barrier.
In both the acute and the subacute stages of isch emic stroke, there is some instability of CBF and CMR02• In addition, CBF becomes poorly reactive to changes in PaC02 or to vasoactive agents and becomes linearly dependent on the systemic blood pressure (loss of autoregulation). To investigate these issues, rapid methods for measurement of CBF and CMR02 are desirable. They may also be useful when testing the effects of therapeutic inter ventions.
In the chronic phase, two important pathophysi ological problems have been clearly documented with PET. One is related to the long-term effects of chronic arterial occlusion, particularly of the inter nal carotid or middle cerebral arteries. It has been shown that these lesions may have hemodynamic consequences of several degrees of severity (Baron et aI., 1981b; Powers et aI., 1984 Powers et aI., , 1985 Powers et aI., , 1987 Gibbs et aI., 1984b; Samson et aI., 1985; Sgouropoulos et aI., 1985; Leblanc et aI., 1987; Levine et aI., 1988) . In the first stage, there is no change in CBF but an increase in the cerebral blood volume (CBV), indi cating a normal autoregulatory vasodilation as a re sponse to decreased cerebral perfusion pressure. In the second stage, the CBF starts to fall as vasodi lation becomes less efficient but this is compen sated for by an increase in the oxygen extraction fraction, indicating the stage of oligemia and pro gressive tissue hypoxia. It is only when this reserve of oxygen extraction has been exhausted that the oxygen consumption starts to fall precipitously J Cereb Blood Flow Metab, Vol. 9, No. 6, 1989 (ischemia). Gibbs et aI. (1984b) have shown that the ratio of CBF to CBV is a very sensitive index of the hemodynamics in the brain distal to carotid occlu sion, A second type of change is seen in the chronic stage of stroke. It is characterized by a metabolic depression in gray matter structures distant from the actual site of damage. These remote effects re flect deafferentation and occasional recovery has been taken as evidence for the phenomenon of di aschisis (Feeney and Baron, 1986; Pawlik et aI., 1985) . The study of these remote met abolic effects may prove important in the under standing of the mechanisms of functional recovery after stroke. It has been emphasized that this re mote metabolic depression is associated with a pro portionately decreased CBF, indicating the preser vation of coupling between perfusion and metabo lism. Although these phenomena occur in the acute stage of stroke, their study is easier in the subacute and chronic stages.
To date, subarachnoid hemorrhage has been little studied with PET methodology (Powers et aI., 1986) but the initial experience suggests that interesting information can be obtained on the consequences of vasospasm in brain tissue. Intracerebral hemor rhage has been little investigated in the acute stage but in the subacute and chronic stages it has been shown to induce remote metabolic depression ef fects that are similar to those found after brain in farction (Heiss et aI., 1985) .
In conclusion, the methodology to implement the measurement of cerebral energy metabolism and hemodynamics in CVD should be capable of inves tigating with sufficient accuracy the following pathophysiological problems: (1) ischemia: low CBF, low CMR02, very high OER;
(2) oligemia: moderately low CBF, normal CMR02, high OER;
(3) luxury perfusion: low, normal, or high CBF, low OER, low CMR02; (4) the CBV/CBF relationship; (5) anaerobic glycolysis: combined measurement of CMR g lc and CMR02; (6) remote metabolic effects: low CMR02 or low CMR g lc, normal OER; and (7) reactivity of CBF and CMR02-CMR g lc to physio logical or pharmacological manipulations.
These measurements should take into account the following problems that may make their mea surement less accurate: (1) tissue edema (increased water content); (2) blood-brain barrier damage; (3) CBF instability in acute stages; and (4) heteroge neous tissue in lesions.
Ideally, measurement of CBF and energy metab olism should be rapid and easily repeatable so that the reactivity of these variables to acute challenge by alteration of blood gas tensions, systemic artery pressures, or drugs can be investigated.
QUALITY CONTROL OF PET MEASUREMENTS
In addition to the methods themselves, there are a number of general issues regarding PET measure ments that are not specific to the problem of CVD but that are of paramount importance to the accu racy of the data obtained. These include the follow ing: (1) The method of attenuation correction, which should use real transmission data if techni cally possible: Measured attenuation has the advan tage that it accounts for attenuation in brain, skull, headholder, and patient support (bed). A require ment is the need for accurate positioning between transmission and emission scans. However, for ac curate results, head movement has to be restricted anyway, even during a single emission scan. There fore, this is not really a problem associated specif ically with the additional transmission scan. A pos sible disadvantage of measured attenuation is the additional scanning time required. However, it should be kept in mind that to obtain reasonable accuracy with geometric correction methods, a transmission scan is still required for outlining skull, headholder, and bed. Emission scans will at best only outline the brain. If there is no uptake of the tracer in part of the cortex (e.g., atrophy), then even this outline of the brain will be distorted. (2) The tomograph used, which should ideally be a mul tiring device to allow the simultaneous acquisition of data from several brain levels and hence reduce scanning time and, for some of the methods, the dosimetry to the patient: The camera should be of high spatial resolution for the study of small struc tures and also to reduce partial volume effects and the mixing of heterogeneous tissue compartments. Good temporal resolution is necessary for the im plementation of some dynamic techniques where scan times of a few seconds are required. (3) An adequate estimation of the input of tracer to the brain, which in most cases implies arterial blood sampling and therefore necessitates radial artery catheterization for the duration of the study, a pro cedure that when carefully done has been shown to be harmless and acceptable to patients (Lockwood, 1985) (see later for details regarding each method). In the experience of the three PET centers repre sented at this workshop, there has been not a single complication, other than trivial wrist bruising, of this procedure in several thousand patients studied to date. (4) An adequate technique for sampling the data generated by scanning, which should ideally include an anatomical reference system and avoid undetected slices, i.e., scanned slices should be contiguous (for a review of this problem, see Mazzi otta and Koslow, 1987). (5) Data bank of control values from normal volunteers of different ages and perhaps also from asymptomatic subjects with vas cular risk factors (Wise et al., 1986) . (6) Correction of measured original data for loss of brain tissue, e.g., cerebral atrophy, necrosis, and cavitation as seen in chronic cerebrovascular disease (Herscov itch et al., 1986) .
SPECIFIC PROBLEMS ENCOUNTERED IN

CEREBROVASCULAR DISEASE DUE TO THE
CLINICAL STATE OF THE PATIENT
In the acute stage, patients may be poorly coop erative and aphasic, which may cause difficulties in communication and understanding of the PET pro cedure by the patient. This may result in the follow ing problems: Abnormal respiratory patterns, in cluding breath holding, may cause difficulties in the implementation of methods that either involve the inhalation of a radioactive gas in a single breath or rely on continuous inhalation of the gas. Head mo tion may cause serious errors in the final values particularly when dynamic acquisition is used or when the use of two different scans is necessary for the measurement of the oxygen extraction fraction [for example, in the steady-state oxygen-IS tech nique or in the autoradio graphic Mintun-Raichle method (Mintun et al., 1984) ]. It is also a potential problem in the study of anaerobic glycolysis by combined CMR02/CMR g lc measurements.
Other potential problems in seriously sick pa tients may include the following: (1) Instability of respiratory rates and stroke volume, e.g., Cheyne Stokes respiration, may invalidate steady-state ox ygen-IS studies and may induce rapid changes in PaC02, which in turn may cause instability of CBF.
(2) Instability of blood pressure due to spontaneous hypertension following stroke or to antihyperten sive therapy may result in inconstancy of CBF. (3) High hematocrit is frequently seen following an acute stroke and may be treated by hemodilution, which may cause difficulties in methods sensitive to the ratio of peripheral to cerebral hematocrit. (4) Patients may not follow simple commands, e.g., keeping their eyes closed during the PET study so that interpretation of data should take into account the possible presence of visual stimulation. (5) Pa tients are sometimes on anticoagulant treatment, which means that extra care must be taken with arterial catheterization. (6) Cerebral mass effects, such as those due to edema or intracerebral he matoma, may cause displacement of brain struc tures and so invalidate anatomical reference sys tems based on normal brain structures.
MEASUREMENT OF CEREBRAL
BLOOD VOLUME
The interest in measuring CBV by PET is two fold. It is an important physiological parameter and is used as a correction factor in the measurement of energy metabolism (CMR02 + CMRglc). There are problems in the definition of cerebral blood volume since it is composed of at least three components, namely the arterial vessels, the capillaries, and the veins. In addition, vascular spaces within the skull are present, e.g., middle cerebral artery and per haps its branches in the Sylvian fissure and the large dural sinuses, particularly in the posterior fossa.
Methods fo r measuring CBV
Both plasma tracers and red blood cell tracers have been proposed.
Plasma tracers-both 68Ga EDT A and [llC]methylalbumin-have been proposed but these techniques have not been used extensively because of the following two problems: (1) Equilibrium is rarely attainable in the time available because of loss of plasma from blood to tissue spaces (Lam mertsma et aI., 1984) . (2) Blood-brain barrier dam age may invalidate the requirement of sequestration in the vascular space for the tracer.
Red blood cell tracers-carbon monoxide labeled with carbon-ll or with oxygen-15-have been used extensively for measurement of CBV. Although the method has not been validated against another es tablished CBV method, the values found in normal subjects as well as in disease are in agreement with all other known methods (Phelps et aI., I979a) . Car bon-II-labeled CO may be used either by bolus in halation or as a rapid succession of two or three normal inhalations, which is easier in acutely sick patients (Phelps et aI., 1979a; Lammertsma et aI., 1983; Grubb et aI., 1978; Gibbs et aI., I984a; Roland et aI., 1987) . If the patient cannot cooperate, injec tion of autologous red blood cells labeled ex vivo with carbon-ll CO may be used. The measurement of CBV is performed after complete equilibration of the tracer in the blood volume. This method has practical problems, particularly the need to change the cyclotron target if measurements are combined with the use of oxygen-15. In the latter case, spatial resolution may also be different when high resolution scanners are used due to the difference in energy of the positrons. The relatively long physical half-life of carbon-II may create a problem if mea surement of another biological variable is desired after that of CBV. The advantages of carbon-II CO are that it results in good statistics with PET imag ing and one can wait for complete equilibrium even in patients with low cardiac output, although there is a theoretical possibility that in brain areas with very low CBF, equilibrium may be greatly delayed.
Oxygen-15-labeled CO has been used with single or brief inhalations (Martin et aI., 1987; Hawkins et aI., 1986; Yamaguchi et aI., 1986) or given as a con tinuous inhalation (steady-state oxygen-15 model). The first methods result in data with relatively poorer statistics. The steady-state method requires the independent measurement of CBF to measure CBV because the local brain oxygen-IS concentra tion will be a function not only of CBV but also of CBF. However, this steady-state method is ideal for use in the correction of the oxygen extraction ratio in the oxygen-I5 steady-state method (Lam mertsma and Jones, 1983; Pantano et aI., 1985; Lammertsma et aI., 1987a) . The method has only recently been implemented because of problems as sociated with the potential toxicity of CO. How ever, with the development of a method for carrier free labeling of CO by oxygen-IS (Pantano et aI., 1985) , it has been shown that inhalation of Cl50 to equilibrium (which takes only 3 min) and then four additional minutes for data acquisition results in CO contents of arterial blood that are well below acute toxic doses.
Whatever the method chosen, the implementa tion of CBV methods should take account of the following: Collection of adequate counts during brain imaging is difficult because of the small cere bral vascular space, so the duration of scanning must be prolonged. All methods depend on an as sumed value for the local cerebral hematocrit (Lam mertsma et aI., 1984; Loutfi et aI., 1987) . Normal values have been measured infrequently and may be unpredictably affected in CVD. A method has been described to measure cerebral hematocrit di rectly if its value is needed (Lammertsma et aI., 1984; Loutfi et aI., 1987) . The cerebral hematocrit is not significantly variable between different brain ar eas except in the region of large vessels and in pa thology (Lammert sma et aI., 1984; Brooks et aI., 1986a) . In all CBV methods, it must be verified af ter elapse of an appropriate time that arterial plasma does not contain radioactivity above background that (in the absence of hemolysis) confirms the pu rity of the administered CO-contaminant Cl502 would result in spuriously high measured CBV (Martin et aI., 1987) . Except for oxygen-IS CO based measurements, there is no necessity to sam ple arterial blood; venous samples are sufficient. However, since CBV is rarely measured alone, an arterial catheter will usually be already in place. Large vascular pools are not readily distinguishable from true parenchyma. Values of measured CBV using PET may be overestimated in certain regions, e.g., the Sylvian fissures, posterior fossa, and the medial occipital cortex, where dural sinuses and larger arterial branches are present. Regions of in terest should be sited with caution in these areas.
The choice between ox:ygen-1S-and carbon II-labeled CO therefore depends on a number of factors, which have been outlined above, and also on the reason why a CBV measurement is needed. However, two further advantages of oxygen-IS over carbon-II should be mentioned. One is the lower patient dosimetry involved with oxygen-IS and the second is the fact that, following a measure ment of CBV with oxygen-IS, other studies can be performed almost immediately.
MEASUREMENT OF CEREBRAL BLOOD FLOW
Principles and methods
The currently used methods to measure cerebral blood flow with PET are based upon the principles of inert freely diffusible tracers (Kety and Schmidt, 1946) . Kety's tissue autoradiographic technique for the measurement of local brain blood flow in labo ratory animals (Kety, 1960) has been adapted as an in vivo autoradiographic method by Herscovitch et aI. (1983a) and Raichle et aI. (1983) with PET and H2150 as flow tracer. It consists of a bolus admin istration of H2150 or CI502 and a single 40 s PET scan measuring the tissue tracer concentration. During the scan, 150 activity in arterial blood is recorded and local CBF values are calculated as suming a constant brain:blood equilibrium partition coefficient for the tracer. A main assumption of the model is that the tracer is rapidly and completely extracted by the brain tissue, so that there is an immediate equilibrium between blood and tissue. Since H2150 is not freely diffusible across the blood-brain barrier (Eichling et aI., 1974) , radiola belled alcohols like [llC]butanol or [150]butanol have been suggested for use in PET. To overcome the assumption of a fixed partition coefficient, a dynamic series of PET scans allows calculation of both flow and partition coefficient from the time course of the changing tissue activity. This can be done either by directly fitting the measured data to the two-parameter model equation on a pixel by-pixel basis or in a less time-consuming manner by the integrated projection technique (Huang et aI., 1981; Alpert et aI., 1984) . As an alternative to H2150, the gaseous radiotracer fluoromethane la beled with IIC or 18F has been used for CBF studies with dynamic PET (Holden et aI., 1981; Roland et aI., 1987; Beil, 1987) .
In the steady state or equilibrium model, the con tinuous delivery of H2150 is matched by its removal into the venous circulation and by radioactive de cay. The tissue activity accumulates until the input to the tissue is balanced by loss. The resulting steady-state tissue activity is related to the constant input activity as a function of flow, assuming a con stant brain:blood partition coefficient of the tracer.
The physiological status of the tissue must be stable during the buildup and measurement.
The simplest model to quantitate CBF is the mi crosphere or tissue trapping model but it requires a tracer that is completely extracted by the tissue and completely retained during the PET scans. This could be accomplished with labeled microspheres but they cannot be administered intravenously and usage of occlusive particles in humans may carry risks (Brooks et aI., 1986b) . 1 3 N-Iabeled ammonia has been used by Kuhl et aI. (1980) as a nonocclu sive tracer that fulfills the requirements in part. However, it is not completely extracted and the ex traction rate is dependent on the CBF values. Therefore, only semiquantitative results can be ob tained.
In the following sections, we will consider the principles and practicalities of the various CBF methods that are in common use today: (a) single scan autoradiographic, (b) single-scan integrated projection technique, (c) multiple-scan dynamic method, and (d) single-scan equilibrium oxygen-IS method.
Th e autoradiographic method (Herscovitch et aI., I983a; Raichle et aI., 1983) has advantages in that it is a rapid technique, easy to repeat, has high temporal resolution, involves low dosimetry, and is performed by intravenous injection of water or bo lus inhalation of CI502 (Kanno et aI., 1984) . It is therefore a simple method that can be easily imple mented. The main disadvantage is that measure ment values depend on the duration of the scanning time, with longer times resulting in lower flow val ues (Larson et aI., 1987) . There are several possible reasons for this time dependency. They include ce rebral blood volume effects, effects of tissue heter ogeneities, the use of too high an assumed value for the partition coefficient, and finally dispersion and timing errors in the arterial input function. This may be a problem, particularly in ischemia and hypere mia, because there may be differences in local time shifts between the brain and blood curves. Other problems are that the tracer distribution volume is not measured by this technique, it is difficult to ob tain sufficient counts for statistically sound images, and there may be a limitation of water diffusion across the blood-brain barrier. Some of these prob lems, particularly the latter, do not occur if a more diffusible tracer like e IC]butanol is used (Herscov itch et aI., 1987) . On the other hand, difficulties with tracers such as [llC]butanol are a longer haIf-life, difficult production, more uncertainty about the tis-sue:blood partition coefficient, and rapid systemic metabolism.
The errors in the autoradiographic CBF method are as follows: small (less than 5%) errors due to tissue heterogeneity and consequent averaging of tissue activity; less than 5% errors due to variations in the partition coefficient of water; major timing errors-25% for a time shift of 5 s between brain and blood curves; errors that may be as high as 30% due to dispersion of cerebral input function (lid a et aI. , 1986 Dhawan et aI. , 1986) . In addition, the technique is statistically more demanding and requires the acquisition of high count rates in a very short time, which poses particular demands on scanner capabilities (Kanno et aI. , 1984) .
The integrated projection technique's (Huang et aI. , 1981 (Huang et aI. , , 1983 Larson et aI. , 1987) main advantage is that it provides both flow and volume of distribu tion and therefore is accurate even for brain areas with varying water content, including cerebral edema in acute stroke. However, it is not entirely clear that this volume of distribution is the correct one in physiological terms since it is the volume that exchanges during the brief time of the flow mea surement itself. A difficulty is that the method has not been used extensively. The method is sensitive to timing errors (Gambhir et aI. , 1987) , although probably less than the autoradiographic technique. On the other hand, it is more sensitive to tissue heterogeneity.
The dynamic method is still in its developmental phase and it is therefore difficult to judge all of the limitations and to quantify the errors. For example, it is still a point of discussion whether administra tion of tracer should be by a bolus or a ramp injec tion. The main limitation is probably the more com plex scanning protocol. In addition, pixel-by-pixel determination of CBF may be difficult because of statistical limitations and high computational de mands. Errors due to tissue heterogeneity are small (less than 10%) in these methods (Herholz and Pat lak, 1987) ; as for errors due to time shifts and dis persion of input functions, only limited data are available, but in theory they can be modeled and accounted for (Lammertsma et a!. , 1986 (Lammertsma et a!. , , 1987c . There has been no independent validation of any of the dynamic CBF methods so far. Among these methods, the fluoromethane (labeled 18F or with 1lC) (Holden et a!. , 1981; Koeppe et aI. , 1985a,b) approach must be singled out as the only dynamic method that has been extensively used in human studies (Beil, 1987; Roland et aI. , 1987; Levine et aI. , 1988) . It employs a freely diffusible tracer that meets the basic model requirements; however, it has not been independently validated yet, nor sub jected to an extensive analysis of errors. The fluo- 1989 rome thane method is not well suited to combination with metabolic measurements because of the long tracer half-life. Alpert et al. (1984) have proposed a different parameter estimation technique: the weighted integration method. This method is a mul tiple scan extension of the original single-scan inte grated projection method by Huang et a!. (1981) .
Th e steady-state ox ygen-I5 method uses either carbon dioxide or water labeled with 150 by contin uous administration (Jones et a!., 1976 (Jones et a!., , 1985 Sub ramaniam et aI. , 1978) . Its advantages are that it is a simple method in which the sources of method ological errors are easily identified when they occur and that theoretically requires a single arterial sam ple for definition of the input function instead of a dynamic history. However, it has been clearly dem onstrated that the method is sensitive to errors in the arterial value Lammertsma et a!. , 1982) and that it is better to obtain an average arterial value from two to three arterial blood sam ples during the time of acquisition of data from the tissue with the PET camera (Meyer and Yamamoto, 1984; Lammertsma et aI., 1988) . Therefore, an arterial catheter is usually rec ommended. The other advantages of this method are that it is easily combined with oxygen-15 mo lecular oxygen inhalation for measurement of CMR02 and that data with good statistics are readily obtained during imaging because of steady state conditions. The disadvantages of the method have been the matter of numerous rigorous publications (Lam mertsma et aI. , 1981; Herscovitch et aI. , 1983b; Lebrun-Grandie et aI. , 1983; Correia et aI. , 1985; Meyer and Yamamoto, 1984; Steinling and Baron, 1982) . Its main limitation is the nonlinearity of the relationship between the local radioactivity in cere bral tissue and CBF. There is therefore poorer sen sitivity at high CBF (hyperperfusion, activation) and more sensitivity to changes in Vd (Volume of distribution) and PS (permeability surface area pro duce) at high CBF. Also, the mean CBF of hetero geneous tissue may be underestimated by as much as 20%. Other disadvantages are the potential dif ficulty of achieving a constant equilibrium level in brain, which may be due to problems of constant delivery of labeled gas from the cyclotron or from irregularity in breathing patterns, or both. How ever, it has been shown that the averaging of sev eral arterial blood samples during acquisition al most completely eliminates errors in the CBF due to this problem (Meyer and Yamamoto, 1984; Lam mertsma et a!. , 1988) . If required, this can be elim inated completely by measuring the entire blood curve. The method is unable to measure the volume of distribution of water (and hence tracer), which creates potential errors in heterogeneous and edem atous tissue. The procedure is lengthy since it re quires 10 min of equilibration time plus an acquisi tion time of about 5 min and is therefore not suitable for multiple repeated measurements, although pro tocols have been designed for neurobehavioral studies (Kearfott et al. , 1983) . The requirement for an equilibrium period also means that the method makes relatively inefficient use of the radiation dose delivered to the patient.
Practical aspects of the various methods in cere brovascular disease are summarized in Tables 1  and 2 .
Additional model-related problems: Tracer per meability: all of the methods assume complete ex traction of the tracer during first passage. This as sumption may not hold for water. Eichling et al. (1974) have shown extraction to be flow limited in baboons. Flow limitation has also been demon strated in humans (Paulson et al. , 1977; Herscovitch et al. , 1987) , although there is some discrepancy between these two reports with respect to the mag nitude of this limitation. However, this will only result in underestimation at the higher end of the range of CBF values, i. e. , normal gray matter and in hyperperfusion. There is no such limitation with flu oromethane or butanol because of the high diffus ability of these compounds. The partition coeffi cient of water is usually assumed to be 1 although the exact value remains debated (Herscovitch and . This assumption results in errors in measured CBF for pure white matter as well as for heterogeneous gray and white mixtures but is ade quate for edematous white matter. The autoradio graphic method with [1lC]butanol also assumes a value for this parameter that is probably more un certain (Herscovitch et al. , 1987) . Dynamic meth ods that use either water or fluoromethane are un likely to be affected by such errors since they esti mate the local partition coefficient for the tracer.
Diffusion across physical boundaries probably af fects most methods that use freely diffusable tracers especially between adjacent high and low CBF ar eas. This problem has not been adequately studied so far. Model linearity problems have been dis cussed. Errors are significant for the steady-state technique when hyperemia or normal gray matter is studied. The problem is almost absent in the auto radiographic and dynamic approaches. Errors due to cerebral blood volume are small for all tech niques with the possible exception of areas contain ing large amounts of arterial blood, which especially affect the auto radiographic method (Kanno et al., 1984) , and to a much lesser extent the steady-state oxygen-I5 method . Dynamic techniques are even less sensitive to this problem. The sensitivity of dynamic techniques to intra-arterial activity primarily depends on the method of tracer administration, with techniques using ramp inputs being less sensitive than those using bolus injections (Koeppe et al. , 1987) . In the ory, this sensitivity could be removed completely, by including an arterial compartment in the model equation. However, this will also result in more variability in the obtained flow values. The repro ducibility of the methods has not been fully evalu ated, although data are available for the oxygen-15 steady-state technique .
Problems specific to CVD in the measurement of CBF
Measurement of low CBF
There has been no systematic study of the reli ability of the measurement of CBF at low flows for any of the CBF methods used so far. In all methods, the statistical problems due to low counting in low flow areas must be acknowledged. Here, the oxy gen-15 steady-state technique is well suited for mea surement of low CBF (Lammertsma et al. , , 1982 and has been used in patients with low flows with satisfactory results (Lenzi et aI. , 1982; Wise et aI. , 1983a; Hakim et aI. , 1987; Ackerman et aI. , 1981; Baron et aI. , 1983) .
High CBF Most methods used presently may underestimate CBF at high flows. This is true for the steady-state method because of its nonlinearity (see above), for the dynamic method, and for the autoradiographic water method because of incomplete extraction across the blood-brain barrier. Fully diffusable tracers like e 1C]butanol and e8F]fluoromethane may be more adequate for measuring high flows. However, presently it is unclear which method is best for the assessment of hyperperfusion.
Edema
The ideal method should either use nonwater tracers such as butanol or fluoromethane, or use water and measure the partition coefficient, as in the dynamic method. In the steady-state and auto radiographic methods, errors might arise if signifi cant increases in the tissue water content occur. This will mainly be the case in white matter; in edematous gray matter, no change in water content has been demonstrated.
Problems due to blood sampling
All of the CBF methods require arterial blood sampling in their present state of development. However, Koeppe et ai. (1985a,b) have proposed a CBF method using 18F-Iabeled fluoromethane that allows measurement of CBF with expired air rather than arterial blood sampling by analogy to the xe non-133 inhalation CBF method. The method also requires simulation-mixed venous blood sampling to scale the air curve properly. Recent experience suggests that the method is not readily implemented in CVD because of poor patient cooperation and inhomogeneities of pulmonary perfusion and venti lation.
In both the autoradiographic and the dynamic ap proach, the history of the arterial input must be accurately defined and continuous sampling has been advocated. A number of potential errors may J Cereb Blood Flow Metab, Vol. 9, No.6, 1989 arise, particularly due to delay and dispersion of activity in vessels and blood lines, that may result in systematic errors in measured CBF (lid a et aI. , 1986). A proper method for continuous sampling is still in development although Kanno et ai. (1987) and Iida et ai. (1986, 1988) have recently partially validated their method. When continuous sampling is not available, rapid repeated sampling is gener ally used but this is a difficult procedure in the case of 150 because the multiple blood samples must be processed in the context of the rapid physical de cay. In addition, the possibility of delay and disper sion in the radial artery and cannula should not be overlooked. There is also a risk of inaccurate deter mination of the peak in bolus techniques that may result in large errors in CBF. In CVD patients, such methods of arterial sampling are not contraindi cated inasmuch as hemodilution by venesection is a proposed therapeutic measure in acute stroke. In the chronic stage, repeated measurements of CBF involving substantial blood withdrawal should prob ably be avoided.
MEASUREMENT OF CEREBRAL METABOLIC
RATE OF OXYGEN
The methods Three different methods have been developed for the measurement of CMR02 using PET. The oldest is the oxygen-15 continuous inhalation method pro posed initially by Jones et ai. (1976) and imple mented by Frackowiak et ai. (1980) , which involves the combined use of oxygen-15-labeled CO2 and O2, This method entails first the measurement of CBF with C1502 inhalation followed by measurement of the oxygen extraction ratio (OER) with 1502 inha lation imaging, corrected for recirculating labeled water by the CI502 scan. In addition, for accurate results, a correction for nonextracted intravascular oxygen-15 is needed using a CBV scan (Lam mertsma and Jones, 1983; Lammertsma et aI. , 1983) . The second method, proposed by Mintun et ai. (1984) and Herscovitch et ai. (1985) , involves the combined use of oxygen-I5-labeled CO, water, and molecular oxygen to measure the CBV, CBP, and OER, respectively. In this method, the inhalation of molecular oxygen is used to estimate the OER pixel by pixel by means of an operational equation that explicitly requires the actual values for CBP and CBV in the same pixel. The CBV is usually mea sured by a single inhalation of Cl50 and CBP by the autoradiographic-Iabeled water bolus method, al though the use of [llC]fluoromethane has been re ported (Roland et aI. , 1987) . The third method is the dynamic approach proposed by several authors (Meyer et aI. , 1987 ; Huang et aI. , 1986; Lam mertsma et aI. , 1986 Lam mertsma et aI. , , 1987c Holden et aI. , 1987) . In this method, dynamic PET scans are collected after inhalation of molecular oxygen as single or multiple breaths, or by continuous inhalation. In theory, this permits simultaneous measurement of CBV, CBP, and CMR02 and volume of distribution of water from a single study. However, it has been shown that it may be difficult to obtain a reliable measure ment of CBV and CBP by this approach (Huang et aI. , 1986; Meyer et aI. , 1987) although the measure ment of CMR02 appears to be more robust and re liable. Reliable OER estimates can be obtained by combining dynamic C1502 and 1502 scans (Lam mertsma et aI. , 1987c).
Of the above methods, the first two have been fully validated against an independent non-PET method (Baron et aI. , 1981 c; Rhodes et aI. , 1981; Steinling et aI. , 1985 ; Mintun et aI. , 1984) while the third has been partially validated against other PET methods, namely the Mintun-Raichle method (Meyer et aI. , 1987) and the steady-state technique (Lammertsma et aI. , 1987c) . With respect to error analysis, the steady-state method has been the mat ter of extensive investigations of both statistical (Jones et aI. , 1983 ; Lammertsma et aI. , 1982) and theoretical (Lammertsma et aI. , 1981; Correia et aI. , 1985) errors and its limitations are known in great detail. The Mintun-Raichle method has been only partially investigated.
In clinical research, the steady-state method has been implemented in numerous PET centers in the world that have produced clinically useful data. The Mintun-Raichle method has been implemented only in the original center but is beginning to be used in other centers (Meyer et aI. , 1987 ; Roland et aI. , 1987) . The dynamic method is still in its develop mental stages.
Advantages and limitations of these methods
The steady-state inhalation method
The main limitation of this method is its slow ness, because it requires 10 min of equilibrium plus 5 min of data acquisition. When added to the time necessary for the C1502 study and changing tracers, the whole procedure takes at least 60 min. In addi tion, the interval between the C1 502 and 1502 inha lations makes measurement of CMR02 by this method vulnerable to instability in CBP or CMR02• Other problems of this method are (1) the underes timation of CMR02 in heterogeneous gray/white matter mixtures due to propagation of the error in CBP (see earlier), which may account for up to 20% ; and (2) the overestimation of OER due to non extracted, oxygen-15-labeled oxyhemoglobin re maining in the vascular space of the brain, a prob lem fully investigated by that is particularly serious at low OER and high CBV. Lammertsma et ai. (1983 Lammertsma et ai. ( , 1987a have proposed and validated a method to correct for this error by an additional CBV scan using carbon ll-labeled CO; Pantano et aI. (1985) have shown that the error can also be corrected using oxygen-15-labeled CO inhaled at steady state. Theoretical ly, the accuracy of the correction is improved ) because both the tracer and the underlying model are the same as for the measurement of OER itself (making the actual measurement of CBV unnecessary, which is less accurate with continuous inhalation).
(3) The re quirement of head immobility during the measure ment is due to the fact that the method entails a pixel-by-pixel division of PET scans. Errors in duced by head motion have been estimated by Cor reia et ai. (1985) . (4) Statistical errors in the mea surement of the CMR02 are propagated from that of CBP; hence, the measured value of CMR02 in areas of high flow may be less accurate (Lammertsma et aI. , 1982) . Important advantages of the steady-state method are its simplicity, the need for few arterial blood samples, and the rapid data handling by com puters. A major advantage is the high degree of ac curacy of OER, because the same tracer character istics apply for both C1502 and 1502 procedures.
The Mintun-Raichle method
The Mintun-Raichle method (Mintun et aI. , 1984) has two main advantages. (1) It is rapid; about 40 min in total are sufficient.
(2) It is less sensitive to the problem of tissue heterogeneity than the steady state method. Its main disadvantages are its high sensitivity to errors in measurement of CBP and of CBV, particularly at low CMR02 levels. The cor rection for recirculation of labeled water in this method is only approximate and may result in fur ther errors. Although normal values have not been reported from large series of control subjects by this method, the data reported in clinical papers suggest a larger spread of normal values for CMR02 and OER that may reflect such measurement errors (Gibbs et aI., 1984a) . The spread may also, at least in part, be due to the limited statistical quality of the data. As in the autoradiographic CBF method, the autoradiographic CMR02 method relies on the col lection of counts in a short period of time.
The dynamic CMR02 methods
The main limitation of the dynamic methods ap pears to be the unreliable assessment of CBF and CBV from a single oxygen-15 O2 dynamic sequence if these are needed as well as CMR02. This problem has been reported in a number of simulation studies (Meyer et aI., 1987; Lammertsma et aI., 1987c; Holden et aI., 1987; Huang et aI. , 1986) . In the only validation study published so far, Meyer et ai. (1987) observed the same problem when they com pared their results to those obtained in the same subject by the Mintun-Raichle CBF, CBV, CMR02 approach. The 10 s breath-holding employed by Meyer et ai. (1987) might be difficult for many sub jects and patients. However, breath-holding is not a requirement. The method would still be applicable if a rebreathing technique (a couple of breaths) is used. Lammertsma et aI. (1986 Lammertsma et aI. ( , 1987c ) have re cently proposed a similar method using a continu ous ramp inhalation rather than a single breath method. The need for an accurate input function requires the implementation of a rapid blood sam pling method with fast separation of red blood cells and plasma in order to determine with accuracy the recirculation of labeled water, which becomes sig nificant within the first minute of inhalation. Lam mertsma et ai. (1987c) have experimented with an automated plasma separator but this apparatus is still in the process of development and does have the inherent problem of additional delay and disper sion. Very little has been published about error sen sitivity of the dynamic methods, especially with re spect to accuracy of CMR02 in the face of errors in the description of the input function.
The main advantage of the dynamic method is its ability to determine quantitative regional CMR02 in a very short time. Therefore, this dynamic method will be of great use when repeated rapid determina tion of CMR02 is desired without simultaneous de termination of CBF and CBV. Although the latter can be rapidly measured using the appropriate dy namic or autoradiographic approaches, it should be kept in mind that scan duration is not necessarily the limiting factor. Before an additional investiga tion can be performed, time has to be allowed for the activity of the previous administration to decay. However, these dynamic methods for CMR02 are J Cereb Blood Flow Metab, Vol. 9, No.6, 1989 still being evaluated and have not been fully vali dated against independent nonPET methods. Only normal subjects have been studied so far (Meyer et aI., 1987) , so that it is not known whether the ac curacy of the determination of CMR02 holds up in states of low metabolic rate or in states of uncou pling between CBF and CMR02• Finally, it remains uncertain whether, in practice, the dynamic meth ods will ever be able to provide statistically sound maps of metabolism since they require pixel by-pixel curve fitting for determination of CMR02• It should be realized that dynamic 1502 studies can be combined with dynamic C1502 studies. Al though data are still limited, it seems that OER val ues can be obtained that are as accurate as those obtained with the steady-state method (Lam mertsma et aI., 1987c) , while CBF and therefore CMR02 values are more accurate. In addition, this approach requires less time than the steady-state technique, but a higher degree of complexity is in volved. Further studies will be required to assess fully the potential of dynamic methods.
Implementation of the steady-state and the
Mintun-Raichle method in CVD
The CBV correction
For both methods of measuring OER (and CMR02), it is vital to correct the measured OER for the unextracted label remaining in the vascular space. The Mintun-Raichle method requires that CBV be measured in the same pixel by an indepen dent method. The assumption of a fixed "normal" CBV is not possible because the method is very sensitive to errors in CBV, particularly at low CMR02 values. In addition, assumptions have to be made with respect to arterial and venous fractions that are not needed in the steady-state techniques. In the steady-state method, the CBV correction ef fects depend essentially on the true OER and to a much lesser extent on the actual CBF and CBV values (Pantano et aI., 1985) . Hence, the lower the OER, the larger the overestimation if no CBV cor rection is performed; this overestimation may be up to 50% for OER of about 0.1 but be lower than 5% for OER higher than 0.9 Lammertsma et aI., 1983; Pantano et aI., 1985) . In CVD, since it is difficult to predict what the local OER will be in individual patients, it is necessary to carry out CBV corrections. In addi tion, even if the OER is high in the affected area and CBV correction does not result in a marked effect, it will nevertheless modify the OER in the sur rounding structures and therefore change the over all "contrast" in the OER image. With respect to CBF, the CBV correction will have its maximal ef fect on OER at low CBF, so that errors in areas of relative luxury perfusion (low CBF, low OER) will be largest. Finally, the effects of CBV correction also depend on the actual CBV value such that the higher the CBV, the higher the error. In their work, Pantano et al. (1985) showed that the OER is by and large the most important determinant of the effects of the CBV correction across the whole range of true OER; they suggested that the relationship be tween uncorrected and corrected OER was so tight that a nomogram could be used to correct the OER images without the need for an actual CBV scan. These results were obtained using continuous inha lation of oxygen-15-labeled CO as the CBV correc tion method and therefore are possibly more reli able than the IICO correction method (Lam mertsma and Jones, 1983) . However, though theoretically so, practically, the independence of the IICO method of measuring CBV from regional tissue hematocrit makes the methods likely to be comparable in accuracy. These results require con firmation in a larger patient population. On the whole, therefore CBV correction is necessary in acute stroke except when pure diagnostic imaging is desired (i. e. , simple assessment of the presence of local luxury perfusion, or misery perfusion, or met abolic depression with matched CBF/CMR02 decrease). In patients with chronic arterial occlu sion in which hemodynamic compromise is being sought, the correction for CBV is advisable but less necessary than in acute stroke (unless CBF is very low) because it is an increase in the OER that is generally of interest. If the only abnormality in a given patient is a large increase in the CBV on the occluded side, the error in measured OER due to lack of CBV correction will be very small. How ever, it must be emphasized that the actual value of CBV in such a patient is of greater pathophysiolog ical interest (Gibbs, 1984a,b; so that CBV scans will generally be per formed anyway. With respect to the study of deaf ferentation effects in chronic stroke, a CBV correc tion is again advisable but not necessary because the OER is generally normal and symmetric in deaf ferented areas, so the error will be uniformly dis tributed and the assessment of metabolic depres sion will not be affected to any practical degree.
The errors in measurement of CMR02 due to het erogeneity of local CBV in analyzed regions of in terest are very small for the steady-state technique (Lammert sma and unless one is deal ing with a large blood pool adjacent to brain tissue. For the Mintun-Raichle method, this effect has not been tested formally although it is clear that the actual measurement of CBV for each pixel is nec essary for accurate implementation.
Heterogeneity of tissue CBF
The steady-state technique is sensitive to the ef fect of CBF heterogeneity in sampled tissue as a result of the error in CBF (see earlier). The under estimation of measured CMR02 may be as high as 20% in normal tissue composed of 50% gray matter and 50% white matter. This error will be much less if the heterogeneity includes low CBF values; hence, in a tissue that is progressively recovering from low CBF, underestimation of CMR02 will in crease with elapsing time, resulting in a flattening of the recovery curve. In the autoradiographic method, the errors due to tissue heterogeneity are much less than in the steady-state technique. Dy namic models have not been tested for this error so far but theoretically should be less sensitive than the steady-state method.
Heterogeneity of tissue partition coefficient for water
Both CMR02 methods assume a constant parti tion coefficient for water in the calculation of CBF, which results in errors in average CBF in a given region of interest if a mixture of gray and white matter is present, which is generally the case even using third-generation PET scanners. These errors in CBF have been described for the steady-state technique (Lammert sma et aI. , 1981; Steinling and Baron, 1982) but there is no such description for the Mintun-Raichle method. However, from first prin ciples, it is clear that the steady-state method will be more sensitive to this problem than the autora diographic approach because of the nonlinearity in herent in the model. There is no immediate solution to this problem unless methods are validated with independent measurement of the partition coeffi cient of water. The dynamic labeled water tech niques that measure CBF also provide an estimate of partition coefficient but the values are in tum affected by the partial volume effect. Huang et al. (1983) found with their dynamic method an average partition coefficient of water of 0. 81 mllg for seven studies in normal subjects. Higher values have been reported with dynamic methods (Lammertsma et aI. , 1987c) . The true value of the brain-blood par tition coefficient for water remains the subject of some debate. Herscovitch and Raichle, reviewing the literature, suggested that the real value should be 0. 90 ml/g for the average gray/white matter mix ture but they pointed out that this value will change from region to region even across different gray matter areas. It will also be affected by age and blood hematocrit as a result of the different water contents of red blood cells and plasma. When CBF and CMR02 are expressed per ml of brain tissue, the true value for the average partition coefficient should be closer to 1.
Accuracy in measurement of low CMR02
The steady-state technique allows reasonably ac curate measurement of low CMR02 values pro vided the CBV correction is carried out. This is particularly true when low CMR02 is associated with low CBF and decreased OER (relative luxury perfusion in necrotic areas). Since CBF is generally low in low CMR02 areas, the underestimation of CMR02 due to heterogeneous flow compartments is reduced greatly in such areas. As far as statistics go, it was shown by Lammertsma et al. (1982) that this is not a critical issue in the accuracy of mea surement of low CMR02; in addition, data acquisi tion can be prolonged when low CMR02 states are suspected in order to improve counting statistics.
With respect to the Mintun-Raichle method, the measurement of low CMR02 values is subject to more uncertainty because of the high sensitivity to errors in measurement of local CBF and CBV. Here again the dose administered to a patient suspected of low CMR02 values can be increased in order to improve the accuracy of the measurement.
Practical issues in the implementation of these methods in CVD patients
Breath-holding and the use of mouthpieces are practical difficulties in the Mintun-Raichle method when acute CVD patients are studied. The overall length of the study is a critical issue and it is clear that the steady-state method, particularly when a CBV scan is needed, is of a duration such that it can become impractical in uncooperative patients. Head motion is a problem in all CMR02 techniques, although least so in dynamic single 15 02 methods, and inevitably creates artifacts in the OER and in turn the CMR02 images. However, there exist ex cellent head restraint systems for PET scanning that serve to alleviate this problem. The ease and sim plicity of defining the arterial input function in the steady-state technique deserves emphasis. Both the Mintun-Raichle and the dynamic methods require complex arterial blood sampling procedures that may result in inaccuracies in the measurement of CMR02• However, the development of improved methods for continuous arterial sampling and plasma separation should improve the accuracy of these methods and result in simpler implementa tion.
J Cereb Blood Flow Metab, Vol. 9, No.6, 1989 MEASUREMENT OF CEREBRAL METABOLIC
RATE OF GLUCOSE, CMR glc
The methods
{Il Cj D-glucose Despite its first description in 1978 by Raichle et aI., the use of carbon-ll-labeled o-glucose for the measurement of local CMRglc has not been vali dated as yet. This is due to several problems. There is a radiochemical problem such that the usual methods for labeling o-glucose result in ubiquitous labeling of all six carbons, which results in the rapid appearance of carbon-II-labeled CO2 in the tissues of the body as well as the brain, which in turn causes loss of tracer from tissue, as well as recir culation of labeled CO2 (Jones et aI., 1983) . It is difficult to account for this loss of activity in the implementation of the model. To overcome this problem, it has been proposed that data acquisition should last only 1 or 2 min, but then the signal from the metabolic compartment in brain is small and IIC02 production is already significant. Blomqvist et al. (1985) showed that the method should work if an assessment of the egress of IIC02 from brain were estimated by jugular vein sampling. This im plementation has not been fully developed. The other possibility is to label o-glucose with carbon-11 in the six position of the carbon ring only. Such a strategy might solve the problem because the pro duction of carbon-II CO2 would be significantly de layed. Synthesis of this compound has not been re ported yet (Hawkins et aI., 1985) .
Deoxyglucose
Following the classic work of Sokoloff and col leagues (1977) in animal autoradiography, deoxy glucose has been used in humans for measurement of CMRglc (Phelps et aI., 1979b ,. Reivich et al., 1979 . Two glucose analogs have been labeled with positron emitters and have been successfully used: carbon-II-labeled 2-deoxy-o-glucose (2DG) and 2-esF]fluoro-2-o-deoxyglucose (FDG) (Phelps et aI., 1979b; Reivich et aI., 1979 Reivich et aI., , 1982 . In normal subjects, these methods have been partially vali dated since they provide CMRglc values that are in agreement with whole brain CMRglc values pro vided by the Kety-Schmidt method, and the "lumped constant" has now been independently measured by Reivich et al. (1985) both for 2DG and FDG (although the inherent assumption that k4 = 0 was made). This method has been subjected to an extensive analysis of model-related errors and lim itations and numerous refinements have been pub lished since its first description (Huang et aI., 1980 (Huang et aI., , 1981 Brooks, 1982; Wienhard et aI., 1985; Hutchins et aI. , 1984; Jagust et aI. , 1986; Lammertsma et aI. , 1987b; Kato et aI. , 1984) . However, in pathological states, the analog can only provide an approxima tion of real glucose utilization and uncertainties re garding the true value of CMRglc cannot be elimi nated even if all possible precautions are taken. This is because glucose-6-phosphate has two prin cipal metabolic fates and "the lumped constant" becomes inconstant in certain pathological states (Hawkins et aI. , 1981 (Hawkins et aI. , , 1986 Crane et aI. , 1981) .
Description of th e deoxyglucose PET method: The so-called in vivo autoradiographic approach re mains the most widely used method of measuring CMRglc because of its inherent simplicity. The method is based on the original Sokoloff operational equation:
where C p is the plasma glucose concentration (as sumed to be constant during the experiment) and LC the so-called "lumped constant. " kl' k2' and k3 are the rate constants for the transport and phos phorylation of the labeled deoxyglucose for the sub ject; kl ' k2' and k3 the mean values of these rate constants in a population of control subjects; Ci (1) is the PET -measured total tissue radioactive con centration at time T (45 min); and CE(1) and CM (1) the radioactive concentrations of the tissue sub strate and phosphorylated analog predicted by the kinetic model with k I, kz , and k3 as set parameters.
Based on human PET data obtained at later times, Phelps et al. (1979b) essentially proposed the same formula but added a k4 in the set of model parame ters used for CE (1) and CM(1) computation. As op posed to the CBF model, the major feature of this method [which we will refer to as the SP (for Sokoloff/Phelps) method in the following] is that it expresses the CMRglc as a linear function of the measured PET data, i. e. , Ci (1). However, the for mula gives only an approximation of the true met abolic rate because of the deviations of the individ ual subject's rate constants from the population mean rate constants. As a matter of fact, the basic hypothesis of the SP method is that CM(1) is pro portional to the metabolic rate while CE(1) is as sumed to be independent of it. The bracketed term can thus be interpreted as the ratio of the current CM(1) [estimated as Cl 1) -CE(1)] to the mean CM (1) .
Because this assumption has been shown to be quite sensitive to the amplitude of the deviations of the subject rate constants from the population mean rate constants (Huang et aI. , 1980; Hawkins et aI. , 1981) , alternative formulas based on different hy potheses have been developed by several authors. Brooks observed that the calculation of the quantity Ci (1) [the total model predicted tissue radioactive concentration at time T = CE(1) + CM(1)] could be rewritten as the sum of two functions, a slowly de caying one Cs(1) and a rapidly decaying one CR (1), both being the product of a constant coefficient and the convolution of the plasma time-activity func tion with an exponential. The constant coefficient of Cs (1) being nearly equal to the ratio k1 . k3/(k2 + k3) suggested that Cs (1) [instead of CM(1) as in the SP method] would be proportional to CMRglc , and would make the following formula less sensitive to deviations of the rate constants from the normal mean values:
Cs (1) (2)
Another formula of interest has been proposed by Hutchins et al. (1984) . In their approach, C/1) is the quantity assumed to be proportional to CMRglc , which leads to the formula (3) Because the quantities CE(1) and CM(1) are linearly dependent on kl' the CMRglc estimated using this formula are independent of the kl value, a very in teresting property, especially in the context of CVD.
In addition, Wienhard et al. (1985) and have proposed simplified equations. In all of these equations, there are the underlying as sumptions that the "lumped constant" is known and stable across pixels, that deviations from stan dard rate constants defined in normal subjects are not too large, and that the arterial input function has been accurately characterized. In addition, the problem of whether glucose phosphatase activity is of sufficient magnitude significantly to effect mea surement of CMRglc has been the matter of exten sive biochemical studies with the likelihood that in humans such an effect is significant only with longer and later scan times beyond 45 min (Nelson et aI. , 1985; Phelps et aI. , 1979b; Huang et aI. , 1980) .
The dynamic approach has been implemented in two different ways. The first depends on a graphical analysis that is linear if k4 = 0 and that provides the kl . k3/(k2 + k3) ratio by linear fitting (Patlak et ai., 1983) . However, this method has failed to provide linear plots in humans presumably because k4 > 0 (although this does not necessarily imply that this is due to glucose phosphatase activity). The graphical plot is never quite linear so that the estimation of CMRglc by this method remains uncertain. Dynamic curve fitting after administration of labeled deoxy glucose probably remains the most accurate way of determining CMRglc. However, there has not been a study describing accurate pixel-by-pixel curve fitting procedures in implementation, although this is not essential to the method. Fitting procedures should account for the following problems : (1) Cor rection for radioactivity within the vascular space is critical in the early phases for accurate curve fitting. This can be performed either by means of an addi tional CBV scan, or (more accurately) by including the vascular space in the model so that it can be taken into account in the fitting procedure (Hawk ins et aI., 1986) .
(2) It is necessary to sample brain radioactivity rapidly with PET in case the vascular space is included in the model (Hawkins et aI., 1986) . (3) The input function must be well charac terized. Fast or continuous sampling of blood is necessary to define peak activity accurately. The time shift between brain and blood is critical and this can be either estimated by detection from the brain peak by actual monitoring of the count rates or by fitting for delta-T in the curve-fitting proce dure (Mazoyer et aI., 1986) . Smearing and disper sion effects are much less critical for CMRglc than for measurement of blood flow or oxygen consump tion. The curve-fitting procedure is time consuming and requires dedicated powerful computers. A number of laboratories have published pixel by-pixel estimations of the individual deoxyglucose rate constants (Baron et aI. , 1984; Heiss et aI., 1984; Rougemont et aI., 1984; Sasaki et aI. , 1986; Her holz, 1988) but the curve-fitting procedures used by the various authors did not take into account all of the above factors.
Despite these methodological advances in the re gional determination of k values, it has not been demonstrated that knowledge of individual deoxy glucose rate constants in the brain on a regional basis is of significant physiological interest, al though isolated reports suggest they may be (Wi en hard et aI., 1985) . Acknowledging the fact that the use of normal rate constants in the autoradiographic operational equation may lead to considerable er rors in CVD, especially in the acute stages of isch emia (Hawkins et aI., 1981; Baron et aI., 1984; Wienhard et aI., 1983; Hakim et aI., 1987) , then curve fitting is required. It should be realized that the ratio kJ . k 3 /(k2 + k 3 ) is much more accurately J Cereb Blood Flow Metab, Vol. 9, No.6, 1989 estimated than the individual rate constants. Wien hard et aI. (1985) have proposed that in this case the first 3 min of the brain curve may be discarded in order to limit the influence of the vascular fraction correction and attenuate errors due to adjustment of blood and brain curves and peaks, although the va lidity of this approach in abnormal tissue is still a matter of debate (Lammertsma et aI. , 1987b) .
CMR g [c measurements with deoxyglucose in CVD: As a general rule, the dynamic method of measuring CMRglc in CVD will provide more reli able metabolic estimates than the autoradiographic method. This is particularly true in the acute stages of ischemic stroke when massive changes in the rate constants and the "lumped constant" may make the autoradiographic approach very unstable (Hawkins et aI., 1981; Baron et aI. , 1984; Huang et aI., 1980; Hakim et aI., 1987 ; Gj edde et aI., 1985 ; Lammertsma et aI., 1987b) . In the chronic stages of CVD, the errors introduced by the use of the auto radiographic approach are considerably less serious and in most instances the autoradiographic ap proach will provide reasonable accuracy. Of the dif ferent versions of the operational equation for the auto radiographic approach, the Sokoloff/Phelps version is probably the most sensitive to deviations in the rate constants and its use sometimes results in negative CMRglc values (Huang et aI., 1981; Hawkins et aI., 1981; Baron et aI., 1984; . The other versions of the operational equation, namely the Rhodes et al. version (1983 ), the Hutchins et al. version (1984 , the Brooks (1982) version, and the Wienhard et al. (1985) approach, are all similar although less accurate than fitting for individual rate constants (Lammertsma et al., 1987b; Wienhard et aI. , 1985) . The choice of whether to use the autoradiographic or dynamic ap proach will depend on what is expected from the PET study. If diagnostic imaging is the goal, then the autoradiographic approach is sufficient and in fact results in an enhancement of the contrasts be tween normal and hypometabolic areas since under estimation of low metabolic rates is the rule. If, on the other hand, measurements of glucose consump tion are the goal, then a dynamic approach is rec ommended. However, as mentioned above, the method of carrying out the dynamic study optimally remains incompletely settled. In addition, the dy namic method is not convenient to apply in CVD patients if they are uncooperative. Hawkins et aI.
( 198 1) and Wienhard et al. (1985) have proposed ways of minimizing the errors in autoradiographi cally measured CMRglc in CVD patients by normal ization approaches. Hawkins et aI. (1981) suggested the use of "ischemic rate constants" rather than standard rate constants, which he determined from a small group of five patients with recent stroke. Wienhard et ai. (1985) proposed normalizing the rate constants by comparing the uptake of deoxy glucose in brain relative to the blood curve and sug gested that this method resulted in fewer errors in the determination of CMRglc. The two empirical ap proaches have not been formally investigated in large numbers of patients, which makes assessment of their real value difficult at present. Finally, Wil son et ai. (1988) proposed the use of Bayesian esti mation for CMRglc using the mean covariance ma trix of the rate constants both in the popUlation of controls and in the population of ischemic patients and selecting the estimate producing the highest value for the posterior density of CMRg1c-Although preliminary, results obtained with this method on simulated data seem to be at least as good as the results obtained by the other methods.
Th e "lumped constant" in CVD: Changes in the "lumped constant" are expected to occur in the acute stages of cerebral ischemia because of the occurrence of uncoupling between glucose supply and demand, supply becoming a limiting factor for glucose utilization (Crane et aI. , 1981; Hawkins et aI. , 1981; Gjedde et aI. , 1985 ; Nakai et aI. , 1987) . In chronic stages of CVD, however, there is no reason to expect large changes in the lumped constant un less there is significant hemodynamic compromise distal to arterial occlusion.
There remains some uncertainty as to the exact value of the normal "lumped constant" (LC) for FDG. The initial value empirically derived by Phelps et ai. (1979b) was 0.42 and more recently 0.50 by Brooks et ai. (1987) . It has been directly measured by Reivich et ai. (1985) , who found a value of 0.52, assuming k4 = O. For the sake of uniformity, the actual value used should be quoted in all publications. This will allow direct compari son of numerical values because the LC is a linear scaling factor in the operational equations. It has also been proposed that if CMR02 is measured con currently, an empirical LC based on the relation ship between glucose and oxygen consumption in normal subjects (02: glucose = 5.6: 1) could be used (Frackowiak et aI. , 1988) , but this depends on the implementation of both the CMR02 and the CMRglc techniques (Lammertsma et aI. , 1987 b) . Methods have been proposed to assess the stability of the LC in acute stroke (Hawkins et aI. , 1981 (Hawkins et aI. , , 1986 Gjedde et aI. , 1985) . The UCLA group suggest assessment of the individual rate constants and then the ratios of k41k3 and k21k3 (Phelps et aI. , 1983) . In subacute stroke and in brain tumors, they found using these estimates that the stability of the LC was not greatly altered by disease (Hawkins et aI. , 1986) . Gjedde et ai. (1985) proposed the combined use of carbon-ll methylglucose in order to assess glucose transport across the blood-brain barrier and hence derive in formation on the glucose content of brain tissue, which determines the lumped constant. In this man ner, they estimated the FDG LC in apparently nor mal brain tissue in stroke patients and found an av erage of 0.45 , which is in reasonable agreement with other methods. In pathological regions, they sug gested that the LC could increase by as much as fivefold ! Because of the nonlinearity of the relation ship between brain glucose content and the LC, the actual value of the LC found in situations of isch emia is presumably of limited accuracy. Although these methods of estimating the stability of the LC in CVD are of great potential, their validity has not been investigated in depth and their use has re mained very limited so far.
With respect to carbon-II-labeled 2deoxyglucose, there is little information on the lumped constant. Reivich et ai. (1985) measured it directly in normals and found the value to be 0.56,
The uncertainties in the determination of CMRglc in acute stroke must be acknowledged since they make interpretation of the findings difficult in terms of energy metabolism. It is therefore recommended that CMR02 be preferred in these clinical instances. However, when assessment of anaerobic glycolysis is desired, it is necessary to obtain the measurement of CMRglc coupled with that of CMR02 (Baron et aI. , 1984 ; Wise et aI. , 1983b; Hakim et aI. , 1987 ; Frackowiak et aI. , 1988) .
Miscellaneous problems in CVD: Breakdown of the blood-brain barrier does not seem to induce sig nificant errors in the measurement of CMRglc (Hawkins et aI. , 1986) , although this has not been tested formally in CVD. Correction for cerebral blood volume is necessary in the dynamic ap proaches aimed at measuring the individual rate constants; however, it is not necessary in the auto radiographic method. The time constraints of the deoxyglucose method limit its use in the acute stage because a physiological steady state is required for the entire duration of the study. In the autoradio graphic approach, imaging is delayed to at least 35 min after tracer injection, although this depends on the actual rate constants and degree of hypometab olism, and it would probably be safer to delay im aging further (Hawkins et aI. , 1981) . In the dynamic approach, if the measurement of CMRglc without knowledge of the individual rate constants is de sired, then the whole study may last only 30 min, but the patient must still remain in the PET camera throughout data acquisition-the time for imaging may be considerably shorter in the autoradio graphic approach. If individual measurements of the rate constants including k4 are desired, much longer scanning times are necessary. Impurities in the injectate of fluorine-18-labeled FOG, e.g., fluo rine-18-labeled deoxymannose, must be avoided by implementing appropriate radiochemical syntheses of FOG (the actual effect of this impurity on mea sured CMRglc has not been estimated). The choice between FOG and 20G must be made according to the protocols to be used. The reproducibility of the measurement is about the same (Reivich et aI., 1982) . The use of carbon-II-labeled 20G has been advocated for repeat studies (activation studies, therapeutic intervention) because of the shorter half-life of carbon-II, permitting two studies in 1 day (Reivich et aI., 1982) . However, methods have recently been proposed using a double injection of FOG to overcome this limitation (Chang et al. , 1987) .
CONCLUDING REMARKS
This paper has sought to summarize the various techniques for measuring cerebral blood flow and energy metabolism in cerebrovascular disease using PET. The approach has been deliberately practical and it is hoped will serve to help those setting up methods de novo to tailor their choices to the clin ical (scientific) question at hand, taking into consid eration the constraints imposed by hardware and other local considerations.
